Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on OncoSil Medical.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: OncoSil up 15pc on German device funding; Starpharma expands to Middle East
News
Top 10 at 10: The ASX stocks looking succulent and stale this morn
News
ASX Lunch Small Cap Wrap: Who’s scrambling to the Christmas finish line this morning?
Health & Biotech
ASX Health Stocks: OncoSil and Neuroscientific Biopharma release positive clinical results
News
10 at 10: These ASX stocks are gifts that keep on giving this morning
News
Last Orders: Tech stocks lost nearly 2 per cent; but the rest of the ASX in the green
News
Last Orders: What you might have missed on the ASX today
News
10 at 10: These ASX stocks are firing the cannons this morning
Experts
Scopo’s powerplays: Strap yourselves in for some M&A
Health & Biotech
Health Kick: Pancreatic cancer treater OncoSil continues impressive bounce-back
News
Small caps were still raising money in May; health beat resources again
Experts
ScoPo’s health powerplays: The transition to greatest
Health & Biotech
Check up: Is anyone making non-COVID-19 money these days? Actually, yes
News
10 at 10: These ASX stocks are flying high this morning
News
10 at 10: These 10 ASX stocks are reaching high this morning
News
Trading Places: Here are this week’s substantial holder movements
Health & Biotech
